132 related articles for article (PubMed ID: 564059)
1. Short- and long-term effects of intraventricular 6-hydroxydopamine in rats pretreated with a monoamine oxidase inhibitor.
Vetulani J; Reichenberg K; Wiszniowska G; Marchaj J
Pol J Pharmacol Pharm; 1977; 29(6):645-56. PubMed ID: 564059
[TBL] [Abstract][Full Text] [Related]
2. Comparison of central effects of noradrenaline and dopamine injected into the lateral brain ventricle in rats.
Zebrowska-Lupina I; Malec D; Kleinrok Z
Acta Physiol Pol; 1975; 26(3):261-74. PubMed ID: 1242288
[TBL] [Abstract][Full Text] [Related]
3. [Role of brain biogenic amines in the central thermoregulatory mechanism of the rat (author's transl)].
Fukushima N
Hokkaido Igaku Zasshi; 1975 Jul; 50(4):369-85. PubMed ID: 1240080
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of central action of octopamine.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1979; 31(5):509-16. PubMed ID: 121158
[TBL] [Abstract][Full Text] [Related]
5. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
[TBL] [Abstract][Full Text] [Related]
6. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
Peterson DW; Sparber SB
J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
[No Abstract] [Full Text] [Related]
7. The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats.
Vetulani J; Reichenberg K; Wiszniowska G
Psychopharmacologia; 1974; 38(2):173-80. PubMed ID: 4460073
[No Abstract] [Full Text] [Related]
8. Central pharmacological effects of long-term application of piracetam in rats.
Felińska W; Bień E
Pol J Pharmacol Pharm; 1991; 43(1):7-13. PubMed ID: 1771165
[TBL] [Abstract][Full Text] [Related]
9. Central action of adrenaline.
Jagiełło-Wójtowicz E
Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
[TBL] [Abstract][Full Text] [Related]
10. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
Robbins TW; Roberts DC; Koob GF
J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
[TBL] [Abstract][Full Text] [Related]
11. Behavioural effects of dopamine and 5-hydroxytryptamine in centrally chemosympathectomized rats.
Herman ZS; Brus R; Szkilnik R
Pol J Pharmacol Pharm; 1976; 28(5):463-7. PubMed ID: 1012976
[TBL] [Abstract][Full Text] [Related]
12. A study of the central effects of 5,6-dihydroxytryptamine.
Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
[No Abstract] [Full Text] [Related]
13. 5-hydroxydopamine, unspecific centrally acting false neurotransmitter.
Brus R; Herman ZS; Szkilnik R; Dzikowski A; Opielka L; Bonczek A
Acta Physiol Pol; 1977; 28(1):13-21. PubMed ID: 868521
[TBL] [Abstract][Full Text] [Related]
14. Central effects of octopamine administered into the lateral ventricle of rats.
Kleinrok Z; Jagiełło-Wójtowicz E; Szkilnik E
Acta Physiol Pol; 1979; 30(4):445-53. PubMed ID: 228526
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric behavioral and biochemical effects of unilateral injections of 6-hydroxydopamine into the lateral brain ventricle of the rat.
Vetulani J; Reichenberg K; Wiszniowska G
Eur J Pharmacol; 1972 Aug; 19(2):231-8. PubMed ID: 5071793
[No Abstract] [Full Text] [Related]
16. Central effects of prostaglandins F2alpha and E1.
Herman ZS; Kmieciak-Kolada K; Wolny HL; Slomińska-Zurek J; Bonczek A
Pol J Pharmacol Pharm; 1976; 28(5):411-21. PubMed ID: 1012972
[TBL] [Abstract][Full Text] [Related]
17. Central action of glucagon.
Morawska D; Sieklucka-Dziuba M; Kleinrok Z
Pol J Pharmacol; 1998; 50(2):125-33. PubMed ID: 9798264
[TBL] [Abstract][Full Text] [Related]
18. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
Everett GM; Yellin TO
Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
[No Abstract] [Full Text] [Related]
19. The effects of intraventricular 6-hydroxydopamine and 5,6-dihydroxytryptamine on morphine induced locomotor stimulation.
Slater P; Blundell C
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):219-24. PubMed ID: 7402365
[No Abstract] [Full Text] [Related]
20. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
